Related Experiment Video
Updated: May 25, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia1,2, Adaikalavan Ramasamy2, Chen Huei Leo3
1Science, Math & Technology, Singapore University of Technology & Design, Singapore 487372, Singapore.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global health issue affecting over 30% of people. This review explores MASLD pathogenesis and current/investigational therapies for MASLD and its severe form, MASH.
Area of Science:
- Hepatology
- Metabolic Diseases
- Gastroenterology
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally.
- Affecting over 30% of the population, MASLD is characterized by hepatic steatosis linked to metabolic dysfunction.
- It can progress to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, liver failure, and cancer.
Purpose of the Study:
- To provide an overview of MASLD pathogenesis.
- To evaluate current therapeutic strategies for MASLD.
- To review pharmacological agents under investigation for MASLD and MASH.
Main Methods:
- Literature review of pathogenesis.
- Analysis of existing MASLD and MASH therapies.
- Survey of clinical trials for novel pharmacological treatments.
Main Results:
- MASLD involves hepatic steatosis and metabolic risk factors.
- The "multiple-hits" concept suggests dietary, metabolic, and genetic factors contribute to oxidative stress and inflammation.
- Numerous pharmacological agents are in clinical trials for MASLD/MASH.
Conclusions:
- Understanding MASLD pathogenesis is crucial for effective treatment.
- Current research focuses on targeting metabolic dysfunction and inflammation.
- Promising new therapies are emerging for MASLD and MASH.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Acute Pancreatitis II: Clinical Manifestations and Management

